Sandbox:Hannan: Difference between revisions
Jump to navigation
Jump to search
Hannan Javed (talk | contribs) No edit summary |
Hannan Javed (talk | contribs) No edit summary |
||
| Line 2: | Line 2: | ||
|+ | |+ | ||
! rowspan="4" |Myeloproliferative neoplasms (MPN) | ! rowspan="4" |Myeloproliferative neoplasms (MPN) | ||
! | ! colspan="3" | | ||
|- | |- | ||
| | | | ||
| Line 17: | Line 15: | ||
| | | | ||
| | | | ||
|- | |||
!Myeloid/lymphoid neoplasms with eosinophilia and rearrangement of | |||
PDGFRA, PDGFRB ,or FGFR1, or with PCM1-JAK2 | |||
! | |||
! | |||
! | |||
|- | |||
!Myelodysplastic/myeloproliferative neoplasms (MDS/MP | |||
! | |||
! | |||
! | |||
|} | |} | ||
Revision as of 17:57, 14 January 2019
| Myeloproliferative neoplasms (MPN) | |||
|---|---|---|---|
| Myeloid/lymphoid neoplasms with eosinophilia and rearrangement of
PDGFRA, PDGFRB ,or FGFR1, or with PCM1-JAK2 |
|||
| Myelodysplastic/myeloproliferative neoplasms (MDS/MP | |||